Physician profile
Benjamin Abadeer
NPI 1255541603
$2,195.16
in general payments reported to CMS, 2019-2025
12 companies · $2,119 in 2025
The $2,119 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.15 · 2022: $30.49 · 2025: $2,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,469 · Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,468.81 |
| Food and Beverage | $649.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $1,856.28 | 2025 | Prodisc L, Prodisc C |
| Globus Medical, INC. | $70.56 | 2025 | Creo, Coalition Agx, Excelsius Gps |
| Si-Bone, INC. | $49.72 | 2025 | |
| Organogenesis INC. | $46.15 | 2019 | |
| Nexxt Spine LLC | $36.27 | 2025 | Nexxt Spine Technology |
| Boston Scientific Corporation | $35.09 | 2025 | Intracept |
| Vertex Pharmaceuticals Incorporated | $18.70 | 2025 | |
| Heron Therapeutics, INC. | $17.88 | 2025 | Zynrelef |
| Bioventus LLC | $17.84 | 2022 | |
| Mml US, INC. | $17.48 | 2025 | Reactiv8 |
| Hospira, INC. | $16.54 | 2025 | |
| Abbvie INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Abadeer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.